Anthropic introduced Claude Science at an event for pharmaceutical and biotech executives, positioning it as a specialized AI assistant for scientific research workflows. The product mirrors the structure and capabilities of Claude Code, which was launched earlier this year to support software engineering tasks.

Claude Science is designed to autonomously execute certain research tasks—literature review, data analysis, hypothesis generation, and experimental design support. According to Anthropic, the system can identify relevant peer-reviewed publications, synthesize findings across studies, and suggest follow-up experiments. The company built it specifically to understand scientific notation, citation conventions, and domain-specific terminology used in pharmaceutical and life sciences research.

What This Means for Your Business

Life sciences companies and research institutions should evaluate Claude Science as a potential productivity tool for your R&D teams. The autonomous research capabilities could accelerate literature synthesis and hypothesis generation, reducing time spent on routine research administration. However, verify with your compliance and legal teams how AI-generated research suggestions should be documented for regulatory submissions and whether your industry's standards (FDA, EMA) have guidance on AI-assisted drug development workflows.